Evidence map›Paper›PMID 26242202›Full record

ArticleJournal of molecular endocrinology2015

Endothelial glucocorticoid receptor promoter methylation according to dexamethasone sensitivity.

Eugenia Mata-Greenwood, P Naomi Jackson, William J Pearce, Lubo Zhang

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. [Effects of icariin on autophagy and exosome production of bone microvascular endothelial cells].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2019
    Article
  12. Article
  13. Frontiers in immunology · 2017
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eugenia Mata-GreenwoodDivisions of Pharmacology and Physiology Department of Basic Sciences, School of Medicine, Center for Perinatal Biology, Medical Center, Loma Linda University, Room A572, 11234 Anderson Street, Loma Linda, CA 92350, USA ematagreenwood@llu.edu.
P Naomi JacksonDivisions of Pharmacology and Physiology Department of Basic Sciences, School of Medicine, Center for Perinatal Biology, Medical Center, Loma Linda University, Room A572, 11234 Anderson Street, Loma Linda, CA 92350, USA.
William J PearceDivisions of Pharmacology and Physiology Department of Basic Sciences, School of Medicine, Center for Perinatal Biology, Medical Center, Loma Linda University, Room A572, 11234 Anderson Street, Loma Linda, CA 92350, USA.
Lubo ZhangDivisions of Pharmacology and Physiology Department of Basic Sciences, School of Medicine, Center for Perinatal Biology, Medical Center, Loma Linda University, Room A572, 11234 Anderson Street, Loma Linda, CA 92350, USA.
Loma Linda University · US

Funding

Uterine vascular responses to pregnancy and long term hypoxemiaP01HD031226 · NICHD · LOMA LINDA UNIVERSITY · PI LONGO, LAWRENCE D · 1995 to 2014
$21.4M
NIH-LLU Initiative for Maximizing Student DiversityR25GM060507 · NIGMS · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2001 to 2022
$11.3M
Research Training/Education CoreP20MD006988 · NIMHD · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2012 to 2016
$6.2M
Vascular Biology Core FacilityP01NS082184 · NINDS · LOMA LINDA UNIVERSITY · PI PEARCE, WILLIAM J. · 2014 to 2018
$6.1M
Developmental Programming of Ischemic-Sensitive Phenotype in the HeartR01HL118861 · NHLBI · LOMA LINDA UNIVERSITY · PI ZHANG, LUBO · 2014 to 2017
$1.8M
Cerebrovascular Myosin Light Chain Phosphorylation in Fetus, Newborn, and AdultR01NS076945 · NINDS · LOMA LINDA UNIVERSITY · PI PEARCE, WILLIAM J. · 2011 to 2015
$1.5M
NHLBI NIH HHS R01 HL118861NICHD NIH HHS P01 HD031226NIGMS NIH HHS R25 GM060507NIMHD NIH HHS P20 MD006988NINDS NIH HHS P01 NS082184NINDS NIH HHS R01 NS076945
6 · The paper itself

Abstract

We have previously shown that in vitro sensitivity to dexamethasone (DEX) stimulation in human endothelial cells is positively regulated by the glucocorticoid receptor (NR3C1, GR). The present study determined the role of differential GR transcriptional regulation in glucocorticoid sensitivity. We studied 25 human umbilical vein endothelial cells (HUVECs) that had been previously characterized as DEX-sensitive (n=15), or resistant (n=10). Real-time PCR analysis of GR 5'UTR mRNA isoforms showed that all HUVECs expressed isoforms 1B, 1C, 1D, 1F, and 1H, and isoforms 1B and 1C were predominantly expressed. DEX-resistant cells expressed higher basal levels of the 5'UTR mRNA isoforms 1C and 1D, but lower levels of the 5'UTR mRNA isoform 1F than DEX-sensitive cells. DEX treatment significantly decreased GRα and GR-1C mRNA isoform expression in DEX-resistant cells only. Reporter luciferase assays indicated that differential GR mRNA isoform expression was not due to differential promoter usage between DEX-sensitive and DEX-resistant cells. Analysis of promoter methylation, however, showed that DEX-sensitive cells have higher methylation levels of promoter 1D and lower methylation levels of promoter 1F than DEX-resistant cells. Treatment with 5-aza-2-deoxycytidine abolished the differential 5'UTR mRNA isoform expression between DEX-sensitive and DEX-resistant cells. Finally, both GRα overexpression and 5-aza-2-deoxycytidine treatment eliminated the differences between sensitivity groups to DEX-mediated downregulation of endothelial nitric oxide synthase (NOS3), and upregulation of plasminogen activator inhibitor 1 (SERPINE1). In sum, human endothelial GR 5'UTR mRNA expression is regulated by promoter methylation with DEX-sensitive and DEX-resistant cells having different GR promoter methylation patterns.

Indexed as

5' Untranslated RegionsAzacitidineCells, CulturedDecitabineDexamethasoneDNA MethylationDNA Modification MethylasesGene Expression RegulationGlucocorticoidsHumansHuman Umbilical Vein Endothelial CellsNitric Oxide Synthase Type IIIPlasminogen Activator Inhibitor 1Promoter Regions, GeneticProtein IsoformsReceptors, Glucocorticoid5' Untranslated RegionsAzacitidineDecitabineDexamethasoneDNA Modification MethylasesGlucocorticoidsNitric Oxide Synthase Type IIINOS3 protein, humanNR3C1 protein, humanPlasminogen Activator Inhibitor 1Protein IsoformsReceptors, GlucocorticoidRNA, MessengerSERPINE1 protein, human5′UTR mRNA isoformendotheliumglucocorticoidsmethylation

Identifiers

PMID26242202
PMCPMC5113289
OpenAlexW2130667602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.